Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma

被引:18
作者
Stellmacher, F
Sotlar, K
Balleisen, L
Valent, P
Horny, HP
机构
[1] Med Univ Lubeck, Inst Pathol, D-23538 Lubeck, Germany
[2] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany
[3] Hosp Hamm, Dept Med, Hamm, Germany
[4] Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria
关键词
mast cell; mastocytosis; SM-AHNMD; bone marrow; plasmacytoma; plasma cell myeloma; IgM;
D O I
10.1080/10428190310001615693
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An association between mastocytosis and monoclonal gammopathy is a relatively rare but well recognized clinical finding. In the majority of cases, however, overt myeloma or lymphoma is not detectable morphologically. Here we describe the case of a 51 year-old male patient first presenting with paresis of the right facial nerve and the serological finding of IgM kappa paraproteinemia. The patient did not have organomegaly, lytic bone lesions, or urticaria pigmentosa-type skin lesions. Histological examination of a trephine biopsy specimen revealed the unusual coexistence of plasma cell myeloma and mastocytosis. Immunohistochemically, plasma cells were found to exhibit a monotypic staining for Ig heavy chain mu and Ig light chain kappa, thus confirming their neoplastic nature. Mast cells showed prominent spindling and formed dense multifocal infiltrates, thus enabling the diagnosis of bone marrow mastocytosis. Immunohistochemically, mast cells expressed tryptase, chymase, and KIT (CD117). In addition, aberrant expression of CD25 on mast cells was detected, confirming the coexistence of a neoplastic mast cell-proliferative disorder. According to the WHO proposal for classification of hematopoietic malignancies, this unique case, showing the association of two very rare haematologic neoplasms, can therefore best be referred to as bone marrow mastocytosis associated with IgM kappa plasma cell myeloma (SM-AHNMD).
引用
收藏
页码:801 / 805
页数:5
相关论文
共 13 条
[1]   Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases [J].
Andriko, JAW ;
Swerdlow, SH ;
Aguilera, NI ;
Abbondanzo, SL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (06) :742-751
[2]   Abnormal expression of CD antigens in mastocytosis [J].
Escribano, L ;
Díaz-Agustín, B ;
Núñez, R ;
Prados, A ;
Rodríguez, R ;
Orfao, A .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) :127-132
[3]   A case of bone marrow mastocytosis associated with multiple myeloma [J].
Hagen, W ;
Schwarzmeier, J ;
Walchshofer, S ;
Zojer, N ;
Chott, A ;
Sillaber, C ;
Ackermann, J ;
Simonitsch, I ;
Bühring, HJ ;
Drach, J ;
Lechner, K ;
Horny, HP ;
Valent, P .
ANNALS OF HEMATOLOGY, 1998, 76 (3-4) :167-174
[4]   Guidelines for subtyping small B-cell lymphomas in bone marrow biopsies [J].
Henrique, R ;
Achten, R ;
Maes, B ;
Verhoef, G ;
De Wolf-Peeters, C .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (06) :549-558
[5]   Mandibular mass as the presenting manifestation of IgM myeloma in a 22-year-old man [J].
Ho, CL ;
Chen, YC ;
Yiang, YT ;
Kao, WY ;
Chao, TY .
ANNALS OF HEMATOLOGY, 1999, 78 (02) :93-95
[6]   BLOOD FINDINGS IN GENERALIZED MASTOCYTOSIS - EVIDENCE OF FREQUENT SIMULTANEOUS OCCURRENCE OF MYELOPROLIFERATIVE DISORDERS [J].
HORNY, HP ;
RUCK, M ;
WEHRMANN, M ;
KAISERLING, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) :186-193
[7]   Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis:: Evidence for expression of CD2, CD117/Kit, and bcl-xL [J].
Jordan, JH ;
Walchshofer, S ;
Jurecka, W ;
Mosberger, I ;
Sperr, WR ;
Wolff, K ;
Chott, A ;
Bühring, HJ ;
Lechner, K ;
Horny, HP ;
Valent, P .
HUMAN PATHOLOGY, 2001, 32 (05) :545-552
[8]   Acute renal failure in IgM plasmacytoma with hyperviscosity syndrome [J].
Nitschke, M ;
Fink, K ;
PawlowHandt, S ;
Leeker, A ;
Rob, PM ;
Steinhoff, J .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (40) :1213-1216
[9]  
Ogg GS, 1996, CLIN EXP DERMATOL, V21, P365
[10]  
ORNY HP, 2003, J CLIN PATHOL, V56, P575